Robuta

https://www.technologynetworks.com/genomics/news/tekmira-pharmaceuticals-tkmebola-clinical-trial-approved-211313
Investigational New Drug (IND) application for TKM-Ebola has been approved by the United States FDA, allowing Tekmira to initiate a Phase 1 clinical trial.
tekmira pharmaceuticalstkm ebolaclinical trialapprovedtechnology
https://www.biospace.com/tekmira-pharmaceuticals-corporation-intellectual-property-portfolio-solidified-with-granting-of-key-patents-by-us-patent-and-trademark-office
tekmira pharmaceuticalsintellectual propertycorporationportfoliosolidified